ArticlebioRxiv : the preprint server for biology2025

Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects.

Seth F Vigneron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.